GPs set for shingles immunisation programme in elderly patients, says the headline in the Search Medica newsletter
Government advisers have, apparently, recommended a herpes zoster vaccination programme for everyone aged 70 or over, and some other high-risk groups. There seems to be no indication when this will happen, so far, at least.
Experts say that vaccinating patients aged 70 or over would be cost-effective because of the severity and burden of the illness in old people. There is also the possibility of extending the programme to over-65s in future.
The age 70 cut-off is intriguing. The Continue Reading »
GPs set for shingles immunisation programme in elderly patients, says the headline in the Search Medica newsletter
Government advisers have, apparently, recommended a herpes zoster vaccination programme for everyone aged 70 or over, and some other high-risk groups. There seems to be no indication when this will happen, so far, at least.
Experts say that vaccinating patients aged 70 or over would be cost-effective because of the severity and burden of the illness in old people. There is also the possibility of extending the programme to over-65s in future.
The age 70 cut-off is intriguing. The Continue Reading »
GPs set for shingles immunisation programme in elderly patients, says the headline in the Search Medica newsletter
Government advisers have, apparently, recommended a herpes zoster vaccination programme for everyone aged 70 or over, and some other high-risk groups. There seems to be no indication when this will happen, so far, at least.
Experts say that vaccinating patients aged 70 or over would be cost-effective because of the severity and burden of the illness in old people. There is also the possibility of extending the programme to over-65s in future.
The age 70 cut-off is intriguing. The Continue Reading »
GPs set for shingles immunisation programme in elderly patients, says the headline in the Search Medica newsletter
Government advisers have, apparently, recommended a herpes zoster vaccination programme for everyone aged 70 or over, and some other high-risk groups. There seems to be no indication when this will happen, so far, at least.
Experts say that vaccinating patients aged 70 or over would be cost-effective because of the severity and burden of the illness in old people. There is also the possibility of extending the programme to over-65s in future.
The age 70 cut-off is intriguing. The Continue Reading »